Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA
· Real-Time Price · USD
3.50
0.09 (2.52%)
At close: Aug 20, 2025, 9:40 AM
Genenta Science S.p.A. Balance Sheet Statement
Financials in EUR. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 4.58M | 6.19M | 3.69M | 12.21M | 29.79M | 34.67M | 37.24M | 10.55M |
Short-Term Investments | 8.08M | 10.72M | 15.08M | 10M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 1.89M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 308.09K | 364.02K | 980.71K | 2.11M | 1.6M | 803.35K | 1.24M | 1.17M |
Receivables | 1.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | 368.24K | 144.69K | 684.4K | 76.26K | 76.28K |
Other Current Assets | 210.83K | 1.47M | 2.1M | 1.97M | 1.82M | 2.09M | 1.5M | 1.47M |
Total Current Assets | 14.47M | 18.57M | 21.26M | 24.52M | 31.72M | 37.41M | 38.76M | 12.1M |
Property-Plant & Equipment | 42.92K | 83.72K | 57.03K | 102.93K | 111.64K | 65.93K | 23.09K | 20.61K |
Goodwill & Intangibles | n/a | n/a | 53.14K | 87.80 | 87.80 | n/a | n/a | n/a |
Total Long-Term Assets | 351.02K | 447.73K | 1.09M | 2.21M | 1.72M | 869.28K | 1.27M | 1.19M |
Total Assets | 14.82M | 19.02M | 22.35M | 26.73M | 33.44M | 38.28M | 40.03M | 13.29M |
Account Payables | 317.83K | 405.85K | 294.98K | 479.49K | 1.19M | 525.57K | 189.87K | 359.33K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 337.76K | 428.27K | 255.06K | 211.27K | 297.88K | 120.25K | 100.72K | 80.8K |
Total Current Liabilities | 2.1M | 2M | 1.74M | 1.77M | 2.18M | 1.2M | 1.14M | 1.67M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 228.93K | 196.37K | 179.25K | 150.45K | 116.18K | 87.6K | 30.62K | 21.64K |
Total Long-Term Liabilities | 228.93K | 204.35K | 179.25K | 150.45K | 116.18K | 87.6K | 30.62K | 21.64K |
Total Liabilities | 2.33M | 2.2M | 1.91M | 1.92M | 2.3M | 1.29M | 1.17M | 1.69M |
Total Debt | n/a | 21K | 14.59 | 21.00 | n/a | 32.41 | n/a | n/a |
Common Stock | 68.46M | 67.85M | 67.34M | 67.02M | 66.6M | 66.12M | 65.88M | 37.14M |
Retained Earnings | -56.06M | -51.18M | -47.14M | -42.22M | -35.47M | -29.13M | -27.02M | -25.54M |
Comprehensive Income | 88.95K | 150.77K | 231.14K | n/a | n/a | 0.00 | n/a | -0.00 |
Shareholders Equity | 12.5M | 16.82M | 20.43M | 24.8M | 31.14M | 36.99M | 38.86M | 11.6M |
Total Investments | 8.08M | 10.72M | 15.08M | 10M | n/a | n/a | n/a | n/a |